COVID-19 as a catalyst for vaccine manufacturing: A South African experience

Penny L Moore1, Glenda Gray2

  • 1SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.

Cell Host & Microbe
|June 15, 2023
PubMed